SUBSCRIBE
SUBSCRIBE
News   Drug Development

Study Backs Roche Holding AG’s (JOBS) New Use of Avastin Cancer Drug

August 18, 2009 | 
1 min read
Bookmark and Share

Reuters -- Swiss-based Roche Holding AG said on Tuesday a study had showed its drug Avastin increased life expectancy for women with breast cancer without the disease getting worse, when used alongside common chemotherapies.
Clinical research Phase III Europe
MORE ON THIS TOPIC
Megaphone with stethoscope isolated on orange background. 3d illustration
Obesity
Protagonist Enters Obesity Fray With Triple-G Pill, Eyeing 2026 Clinical Start
July 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Wooden blocks with arrow and error icon. Delays and disruptions, stop the process, critical error concept
Lymphoma
Pfizer Ends Mid-Stage Trial for CD47 Blood Cancer Drug, Citing Recruitment Problems
July 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Photo collage of happy businesswoman funny person building stairs way success achieve goals to increase income isolated on white background.
Cancer
Amgen’s Antibody Improves Overall Survival in Phase III Gastric Cancer Test
June 30, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Brain with pills, Alzheimer awareness day, dementia diagnosis, Parkinson disease, memory loss disorder, damaged mind
Alzheimer’s disease
INmune Crashes After Missing Cognitive Target in Phase II Alzheimer’s Trial
June 30, 2025
 · 
2 min read
 · 
Tristan Manalac